BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36368649)

  • 1. AChE as a spark in the Alzheimer's blaze - Antagonizing effect of a cyclized variant.
    Behl T; Kaur I; Sehgal A; Singh S; Sharma N; Gupta S; Albratty M; Najmi A; Alhazmi HA; Bungau S
    Ageing Res Rev; 2023 Jan; 83():101787. PubMed ID: 36368649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.
    Hamodat H; Cash MK; Fisk JD; Darvesh S
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdk5: one of the links between senile plaques and neurofibrillary tangles?
    Lee MS; Tsai LH
    J Alzheimers Dis; 2003 Apr; 5(2):127-37. PubMed ID: 12719630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholinesterase-amyloid-beta-peptide interaction and Wnt signaling involvement in Abeta neurotoxicity.
    Inestrosa NC; Alvarez A; Godoy J; Reyes A; De Ferrari GV
    Acta Neurol Scand Suppl; 2000; 176():53-9. PubMed ID: 11261806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alzheimer's disease: cellular and molecular aspects].
    Octave JN; Pierrot N
    Bull Acad Natl Med; 2008 Feb; 192(2):323-31; discussion 331-2. PubMed ID: 18819686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death.
    Leong YQ; Ng KY; Chye SM; Ling APK; Koh RY
    Metab Brain Dis; 2020 Jan; 35(1):11-30. PubMed ID: 31811496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AChE and the amyloid precursor protein (APP) - Cross-talk in Alzheimer's disease.
    Nalivaeva NN; Turner AJ
    Chem Biol Interact; 2016 Nov; 259(Pt B):301-306. PubMed ID: 27062894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tea polyphenols as multi-target therapeutics for Alzheimer's disease: An in silico study.
    Mazumder MK; Choudhury S
    Med Hypotheses; 2019 Apr; 125():94-99. PubMed ID: 30902161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-beta-peptides.
    Alvarez A; Bronfman F; Pérez CA; Vicente M; Garrido J; Inestrosa NC
    Neurosci Lett; 1995 Dec; 201(1):49-52. PubMed ID: 8830310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression.
    Cole AR; Noble W; van Aalten L; Plattner F; Meimaridou R; Hogan D; Taylor M; LaFrancois J; Gunn-Moore F; Verkhratsky A; Oddo S; LaFerla F; Giese KP; Dineley KT; Duff K; Richardson JC; Yan SD; Hanger DP; Allan SM; Sutherland C
    J Neurochem; 2007 Nov; 103(3):1132-44. PubMed ID: 17683481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholinesterase (AChE)--amyloid-beta-peptide complexes in Alzheimer's disease. the Wnt signaling pathway.
    Inestrosa NC; Urra S; Colombres M
    Curr Alzheimer Res; 2004 Nov; 1(4):249-54. PubMed ID: 15975054
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Jean L; Brimijoin S; Vaux DJ
    J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation.
    Luan K; Rosales JL; Lee KY
    Ageing Res Rev; 2013 Jan; 12(1):174-81. PubMed ID: 22728532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Do Recent Clinical Trials Teach Us About the Etiology of AD.
    Robakis NK
    Adv Exp Med Biol; 2020; 1195():167. PubMed ID: 32468473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity of acetylcholinesterase amyloid beta-peptide aggregates is dependent on the type of Abeta peptide and the AChE concentration present in the complexes.
    Muñoz FJ; Inestrosa NC
    FEBS Lett; 1999 May; 450(3):205-9. PubMed ID: 10359075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.